|
1.
|
|
13 p, 1.2 MB |
Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy : A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research
/
Schoettler, M.L. (Children's Healthcare of Atlanta) ;
Carreras, Enric (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Cho, Byung-Sik (The Catholic University of Korea) ;
Dandoy, Christopher E. (Cincinnati Children's Hospital Medical Center) ;
Ho, Vincent Trien Vinh (Dana-Farber Cancer Institute (Estats Units d'Amèrica)) ;
Jodele, Sonata (Cincinnati Children's Hospital Medical Center) ;
Moissev, I. (Pavlov First Saint Petersburg State Medical University) ;
Sańchez Ortega, Isabel (European Society for Bone Marrow Transplant) ;
Srivastava, Alok (Christian Medical College Vellore) ;
Atsuta, Yoshiko (Aichi Medical University) ;
Carpenter, Paul A. (Seattle Children's Hospital) ;
Koreth, John (Dana-Farber Cancer Institute (Estats Units d'Amèrica)) ;
Kröger, Nicolaus M. (Ohio State. University) ;
Ljungman, Per (Karolinska Institutet (Estocolm, Suècia)) ;
Page, Kristin M. (Medical College of Wisconsin) ;
Popat, Uday R. (The University of Texas MD Anderson Cancer Center) ;
Shaw, Bronwen E. (Medical College of Wisconsin) ;
Sureda Balari, Anna Maria (Institut Catala d'Oncologia-Hospital Duran i Reynals) ;
Soiffer, Robert J. (Dana-Farber Cancer Institute (Estats Units d'Amèrica)) ;
Vasu, Sumithira V. (Ohio State. University)
Transplantation-associated thrombotic microangiopathy (TA-TMA) is an increasingly recognized complication of hematopoietic cell transplantation (HCT) associated with significant morbidity and mortality. [...]
2023 -  10.1016/j.jtct.2022.11.015
Transplantation and Cellular Therapy, Vol. 29 Núm. 3 (march 2023) , p. 151-163
|
|
|
2.
|
|
8 p, 1012.2 KB |
Reduced intensity conditioning increases risk of severe cGVHD : identification of risk factors for cGVHD in a multicenter setting
/
Afram, Gabriel (Karolinska University Hospital and Karolinska Institutet (Suecia)) ;
Simón, Jose Antonio Pérez (Instituto de Biomedicina de Sevilla) ;
Remberger, Mats (Karolinska University Hospital and Karolinska Institutet (Suecia)) ;
Caballero Velazquez, Teresa (Instituto de Biomedicina de Sevilla) ;
Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ;
Piñana, Jose Luis (Hospital Clinico Universitario) ;
Ringden, Olle (Karolinska University Hospital and Karolinska Institutet (Suecia)) ;
Esquirol, Albert (Institut d'Investigació Biomèdica Sant Pau) ;
Lopez-Corral, Lucia (Hospital Universitario de Salamanca-IBSAL) ;
Garcia Cadenas, Irene (Institut d'Investigació Biomèdica Sant Pau) ;
López-Godino, Oriana (Hospital Universitario de Salamanca-IBSAL) ;
Malouf Sierra, Jorge 1971- (Institut d'Investigació Biomèdica Sant Pau) ;
Caballero, Dolores (Hospital Universitario de Salamanca-IBSAL) ;
Ljungman, Per (Karolinska University Hospital and Karolinska Institutet (Suecia)) ;
Vazquez, Lourdes (Hospital Clínico Universitario (Salamanca)) ;
Hägglund, Hans (Uppsala University Hospital) ;
Universitat Autònoma de Barcelona
Chronic graft-versus-host disease (cGVHD) remains a major cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). Aim is to identify risk factors for the development of cGVHD in a multicenter setting. [...]
2018 - 10.1007/s12032-018-1127-2
Medical Oncology, Vol. 35 Núm. 6 (january 2018) , p. 79
|
|
|
3.
|
|
13 p, 1.7 MB |
A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation
/
Cremers, Eline M.P. (VU University Medical Centre) ;
de Witte, Theo (Radboud University Medical Centre) ;
de Wreede, Liesbeth C. (Leiden University Medical Center) ;
Eikema, Diderik-Jan (EBMT Statistical Unit Data Office Leiden) ;
Koster, Linda (EBMT Data Office Leiden) ;
van Biezen, Anja (EBMT Data Office Leiden) ;
Finke, Jürgen (University of Freiburg) ;
Socié, Gerard (Hospital St. Louis) ;
Beelen, Dietrich (University Hospital) ;
Maertens, Johan (University Hospitals Gasthuisberg (Leuven, Bélgica)) ;
Nagler, Arnon (Chaim Sheba Medical Center (Israel)) ;
Kobbe, Guido (Heinrich Heine Universitaet) ;
Ziagkos, Dimitris (EBMT Statistical Unit Data Office Leiden) ;
Itälä-Remes, Maija (HUCH Comprehensive Cancer Center) ;
Gedde-Dahl, Tobias (Oslo University Hospital (Oslo, Noruega)) ;
Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ;
Niederwieser, Dietger (University Hospital Leipzig) ;
Ljungman, Per (Karolinska University Hospital and Karolinska Institutet (Suecia)) ;
Beguin, Yves (University of Liège) ;
Ozkurt, Zubeyde Nur (Gazi University) ;
Anagnostopoulos, Achilles (George Papanicolaou General Hospital (Tessalònia, Grècia)) ;
Jindra, Pavel (Charles University Hospital) ;
Robin, Marie (Hospital St. Louis) ;
Kröger, Nicolaus (University Hospital Eppendorf) ;
Universitat Autònoma de Barcelona
Most myelodysplastic syndromes (MDS)-patients receive multiple red blood cell transfusions (RBCT). Transfusions may cause iron-related toxicity and mortality, influencing outcome after allogeneic HSCT. [...]
2019 - 10.1080/10428194.2019.1594215
Leukemia and Lymphoma, Vol. 60 Núm. 10 (2019) , p. 2404-2414
|
|
|
4.
|
|
8 p, 1.8 MB |
Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT) : an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE)
/
Saccardi, Riccardo (Careggi University Hospital (Florència, Itàlia)) ;
Putter, Hein (Leiden University Medical Center) ;
Eikema, Dirk-Jan (EBMT Statistical Unit Leiden) ;
Busto, María Paula (EBMT Registry) ;
McGrath, Eoin (ICCBBA (Barcelona, Espanya)) ;
Middelkoop, Bas (European Society for Blood and Marrow Transplantation-EBMT Registry) ;
Adams, Gillian (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Atlija, Marina (European Society for Blood and Marrow Transplantation-EBMT Registry) ;
Ayuk, Francis (University Medical Center Hamburg) ;
Baldomero, Helen (University Hospital Basel (Basilea, Suïssa)) ;
Beguin, Yves (CHU of Liège and University of Liège) ;
de la Camara, Rafael (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Cedillo Cedillo, Angel (Grupo Español de Trasplantes Hematopoyéticos y Terapia Celular) ;
Balari, Anna María Sureda (Hospital Universitari de Bellvitge) ;
Chabannon, Christian (Institut Paoli-Calmettes Comprehensive Cancer Centre) ;
Corbacioglu, Selim (University Children's Hospital Regensburg) ;
Dolstra, Harry (Radboud University Medical Center) ;
Duarte, Rafael (Universidad Autónoma de Madrid) ;
Duléry, Rémy (Sorbonne Université) ;
Greco, Raffaella (Autoimmune Diseases Working Party (Barcelona, Espanya)) ;
Gusi, Andreu (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Hamad, Nada (University of Notre Dame Australia) ;
Kenyon, Michelle (King's College Hospital NHS Foundation Trust) ;
Kroeger, Nicolaus (University Medical Center Hamburg) ;
Labopin, Myriam (European Society for Blood and Marrow Transplantation-EBMT Paris Study Office) ;
Lee, Julia (British Society of Blood and Marrow Transplantation and Cellular Therapy (Regne Unit)) ;
Ljungman, Per (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Manson, Lynn (Edinburgh & SE Scotland Clinical Transfusion Centre Patient Services (Regne Unit)) ;
Mensil, Florence (Agence de la Biomédecine) ;
Milpied, Noel (Centre Hospitalier Universitaire Bordeaux) ;
Mohty, Mohamad (Sorbonne University) ;
Oldani, Elena (Italian National BMT Registry) ;
Orchard, Kim (University Hospital Southampton NHS) ;
Passweg, Jakob (University Hospital Basel (Basilea, Suïssa)) ;
Pearce, Rachel (British Society of Blood and Marrow Transplantation and Cellular Therapy (Regne Unit)) ;
de Latour, Régis Peffault (BMT unit Paris Cité University) ;
Poirel, Hélène A. (Belgian Transplant Registry) ;
Rintala, Tuula (King's College Hospital NHS Foundation Trust) ;
Rizzo, J. Douglas (CIBMTR, Medical College of Wisconsin) ;
Ruggeri, Annalisa (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ;
Sanchez-Martinez, Carla (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Sanchez-Guijo, Fermin (CIC-University of Salamanca) ;
Sánchez-Ortega, Isabel (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Trnková, Marie (Czech registry Czech Republic) ;
Valcárcel, David (Vall d'Hebron Institut d'Oncologia) ;
Wilcox, Leonie (Australasian Bone Marrow Transplant Recipient Registry) ;
de Wreede, Liesbeth C. (Leiden University Medical Center) ;
Snowden, John A. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ;
Universitat Autònoma de Barcelona
From 2016 EBMT and JACIE developed an international risk-adapted benchmarking program of haematopoietic stem cell transplant (HSCT) outcome to provide individual EBMT Centers with a means of quality-assuring the HSCT process and meeting FACT-JACIE accreditation requirements relating to 1-year survival outcomes. [...]
2023 - 10.1038/s41409-023-01924-6
Bone marrow transplantation, march 2023, p. 1-8
|
|
|
5.
|
|
11 p, 1.2 MB |
A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients
/
Ljungman, Per (Karolinska Institutet (Estocolm, Suècia)) ;
Bermúdez, Arancha (Instituto de Investigación Sanitaria Valdecilla (Santander, Cantàbria)) ;
Logan, Aaron C. (Division of Hematology and Blood and Marrow Transplantation. Department of Medicine. University of California) ;
Kharfan-Dabaja, Mohamed A. (Department of Blood and Marrow Transplantation. H. Lee Moffitt Cancer Center and Research Institute and University of South Florida) ;
Chevallier, Patrice (Service d'Hématologie Clinique. CHU de Nantes. 44093. Nantes. France and CRCINA / INSERM UMR1232 / CNRS ERL6001 IRS UN - 8) ;
Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ;
Wulf, Gerald (Department of Hematology and Medical Oncology. University Medical Center Göttingen) ;
Selleslag, Dominik (Department of Hematology. AZ Sint-Jan Brugge-Oostende) ;
Kakihana, Kazuhiko (Hematology Division. Tokyo Metropolitan Komagome Hospital) ;
Langston, Amelia (Winship Cancer Institute. Emory University) ;
Lee, Dong-Gun. (Catholic University of Korea) ;
Solano, Carlos (Instituto de Investigación Sanitaria INCLIVA (València, Comunitat Valenciana)) ;
Okamoto, Shinichiro (Division of Hematology. Department of Medicine. Kelo University School of Medicine) ;
Smith, Larry R. (Vical) ;
Boeckh, Michael (Vaccine and Infectious Disease Division. Fred Hutchinson Cancer Research Center and University of Washington) ;
Wingard, John Reid (Division of Hematology & Oncology. Department of Medicine. University of Florida) ;
Cywin, Beth (Astellas Pharma Global Development) ;
Fredericks, Christine (Astellas Pharma Global Development) ;
Lademacher, Christopher (Astellas Pharma Global Development) ;
Wang, Xuegong (Astellas Pharma Global Development) ;
Young, James (Astellas Pharma Global Development) ;
Maertens, Johan (K.U. Leuven and Department of Hematology)
Background: Cytomegalovirus (CMV) is a complication of allogeneic haematopoietic cell transplantation (allo-HCT). ASP0113, a DNA-based vaccine, contains two plasmids encoding human CMV glycoprotein B and phosphoprotein 65 (pp65). [...]
2021 - 10.1016/j.eclinm.2021.100787
EClinicalMedicine, Vol. 33 (march 2021) , p. 100787
|
|
|
6.
|
|
10 p, 1.1 MB |
COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey
/
Ljungman, Per (Karolinska Institutet (Estocolm, Suècia)) ;
de la Camara, Rafael (Hospital Universitario de la Princesa (Madrid)) ;
Mikulska, Malgorzata (Division of Infectious Diseases. University of Genoa and Ospedale Policlinico San Martino) ;
Tridello, G. (Pediatric Hematology Oncology) ;
Aguado, Beatriz (Instituto de Investigación Hospital Universitario de la Princesa) ;
Zahrani, M.A. (King Abdul - Aziz Medical City) ;
Apperley, Jane (Centre for Haematology. Imperial College) ;
Berceanu, A. (Hopital Jean Minjoz) ;
Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ;
Calbacho, Maria (Hospital Universitario 12 de Octubre (Madrid)) ;
Ciceri, Fabio (Ospedale San Raffaele s.r.l.) ;
Lopez-Corral, L. (Hematology Department. Complejo Asistencial Universitario de Salamanca-IBSAL; Centro de Investigación del Cáncer-IBMCC) ;
Crippa, C. (Spedali Civili) ;
Fox, M.L. (Vall d'Hebron Institut d'Oncologia) ;
Grassi, A. (ASST Papa Giovanni XXIII) ;
Jimenez, M.J. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Demir, S.K. (HSCT unit. Demiroglu Bilim University) ;
Kwon, Mi (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Llamas, C.V. (Hospital Universitario de Donostia (Sant Sebastià, País Basc)) ;
Lorenzo, J.L.L. (Hospital Universitario Fundación Jiménez Díaz) ;
Mielke, S. (Karolinska Institutet (Estocolm, Suècia). Department of Laboratory Medicine) ;
Orchard, K. (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ;
Porras, R.P. (Hospital Duran i Reynals (Hospitalet del Llobregat)) ;
Vallisa, D. (Hospital Guglielmo da Saliceto) ;
Xhaard, A. (Hôpital St. Louis) ;
Knelange, N.S. (EBMT Data Office. Department of Medical Statistics & Bioinformatics) ;
Cedillo, Angel (GETH Spanish Registry) ;
Kroeger, Nicolaus (Department of Stem cell Transplantation. University Hospital Eppendorf) ;
Piñana, José Luis (Hospital Clínic Universitari (València)) ;
Styczynski, Jan (Pediatric Hematology and Oncology. University Hospital. Collegium Medicum. Nicolaus Copernicus University Torun)
This study reports on 382 COVID-19 patients having undergone allogeneic (n = 236) or autologous (n = 146) hematopoietic cell transplantation (HCT) reported to the European Society for Blood and Marrow Transplantation (EBMT) or to the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH). [...]
2021 - 10.1038/s41375-021-01302-5
Leukemia, Vol. 35 Núm. 10 (october 2021) , p. 2885-2894
|
|
|
7.
|
|
8 p, 732.8 KB |
Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation
/
Gagelmann, N. (University Medical Center Hamburg-Eppendorf) ;
Eikema, D. J. (EBMT Statistics) ;
Stelljes, M. (University of Münster) ;
Beelen, D. (University Hospital Essen (Alemanya)) ;
de Wreede, Liesbeth C (EBMT Statistics) ;
Mufti, G. (GKT School of Medicine) ;
Knelange, N. S. (EBMT Data Office) ;
Niederwieser, D. (University Hospital Leipzig) ;
Friis, L. S. (University of Copenhagen) ;
Ehninger, Gerhard (Universitätsklinikum Dresden) ;
Nagler, Arnon (Chaim Sheba Medical Center (Israel)) ;
Yakoub-Agha, Ibrahim (Université Lille2) ;
Meijer, E. (Amsterdam UMC. University Medical Center) ;
Ljungman, Per (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Maertens, Johan (University Hospitals Gasthuisberg (Leuven, Bélgica)) ;
Kanz, L. (Universität Tübingen) ;
Lopez-Corral, L. (Hospital Clínico Universitario (Salamanca)) ;
Brecht, A. (Deutsche Klinik für Diagnostik) ;
Craddock, Charles (Centre for Clinical Haematology) ;
Finke, J. (University of Freiburg) ;
Cornelissen, J. J. (Erasmus MC Cancer Institute. Erasmus University Medical Center) ;
Bernasconi, P. (Fondazione IRCCS Policlinico San Matteo) ;
Chevallier, Patrice (CHU Nantes) ;
Sierra, Jorge (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Robin, M. (Hopital St. Louis) ;
Kroeger, Nicolaus (University Medical Center Hamburg-Eppendorf) ;
Universitat Autònoma de Barcelona
The aim of this study was to develop and validate a clinical and transplant-specific prognostic score using data from a large cohort of patients with myelodysplastic syndromes reported to the European Society for Blood and Marrow Transplantation registry. [...]
2019 - 10.3324/haematol.2018.200808
Haematologica, Vol. 104 Núm. 5 (30 2019) , p. 929-936
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
